Historical record - last NADAC publication: 12/10/2014
Product Information
TIAZAC ER 180 MG CAPSULE is a brand product labeled by Bausch Health US LLC, priced at $1.5060 per EA under NDC 00187261390. Its NADAC has been published 41 times since Dec 10, 2014.
The High Outlier badge above means this manufacturer's average price in the diltiazem hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
180 mg/1
Manufacturer
Bausch Health US LLCNDC
00187261390
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
12/10/2014
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020401On Market Since
8/20/2014
Pharmacological Classes
Price Statistics
The NADAC for TIAZAC ER 180 MG CAPSULE has been published 41 times since Dec 10, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5060 per EA |
|---|---|
| All-time high | $1.5060 (Sep 16, 2015) |
| All-time low | $1.5060 (Dec 10, 2014) |
| Median price | $1.5060 |
| Average price | $1.5060 |
| Largest weekly change | 0.0% (Dec 17, 2014) |
| Weeks tracked | 41 |
| Tracking since | Dec 10, 2014 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TIAZAC ER 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIAZAC ER 180 MG CAPSULE, manufactured by Bausch Health US LLC, is $1.5060 per EA (NDC 00187261390), effective Sep 16, 2015.
How has the price of TIAZAC ER 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIAZAC ER 180 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 41 weekly CMS publications since Dec 10, 2014.
What are the highest and lowest recorded NADAC prices for TIAZAC ER 180 MG CAPSULE?
Since Dec 10, 2014, the NADAC for TIAZAC ER 180 MG CAPSULE has ranged from a low of $1.5060 (Dec 10, 2014) to a high of $1.5060 (Sep 16, 2015), with a median of $1.5060 per EA.
Are there cheaper alternatives to TIAZAC ER 180 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TIADYLT ER 180 MG CAPSULE, is $0.1374 per EA — about 91% below TIAZAC ER 180 MG CAPSULE.
Who manufactures TIAZAC ER 180 MG CAPSULE?
TIAZAC ER 180 MG CAPSULE (NDC 00187261390) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification